FDA Indication

Therapeutic Neuromodulation Systems, LLC, a U.S. based sales and marketing organization for the Morph Device, announces the US Food and Drug Administration (FDA) has approved its wearable device for the treatment of opioid withdrawal symptoms. The Morph Device is a percutaneous nerve stimulator for substance use disorders.





By |2018-08-28T17:12:07+00:00May 2nd, 2018|